The Source for Whistleblowers, Journalists, Legislators & Academics

Whistleblower News

China’s Pharmaceutical Bribery Scandal is ‘Tip of the Iceberg’

Chinese authorities are cracking down on its pharmaceutical sector after officials revealed that four China-based senior executives at British drugmaker GlaxoSmithKline had channelled millions of pounds in bribes through travel agencies and consultancies. Reuben Guttman is one of the world’s most prominent whistleblower attorneys who practice with Guttman, Buschner & Brooks PLLC in Washington DC. […]

Read more

Guttman & Buschner Represent Whistleblowers in Justice Dept. $257 Million Civil Settlement with Wyeth over Unlawful Marketing of Rapamune

Pfizer subsidiary pleads guilty to off-label marketing of powerful immunosuppressent Rapamune; settlement latest in series of major off-label whistleblower cases against Abbott, GlaxoSmithKline and Amgen WASHINGTON, DC (July 30, 2013) – Leading whistleblower attorneys Reuben Guttman and Traci Buschner of Guttman, Buschner & Brooks PLLC represented two key whistleblowers behind a $257.4 million settlement announced today […]

Read more

Q&A: Whistle-blower lawyer on Amgen settlement, False Claims Act

This interview with Reuben Guttman was conducted by journalist Terry Baynes with Thomson Reuters. California-based drugmaker Amgen Inc agreed on Tuesday to pay $24.9 million to settle allegations that it provided kickbacks to long-term care pharmacy providers to entice them to switch patients to its anemia drug Aranesp. Whistle-blower Frank Kurnik, a longtime Amgen employee, […]

Read more

$24.9 Million Settlement with Biotechnology Company Amgen, Inc. Resolves South Carolina False Claims Act Lawsuit

PRESS NOTICE BILL NETTLES UNITED STATES ATTORNEY DISTRICT OF SOUTH CAROLINA 1441 Main Street, Suite 500 * Columbia, SC 29201 * (803) 929-3000 April 16, 2013 FOR IMMEDIATE RELEASE CONTACT PERSON: Fran Trapp (803) 929-3000 Fran.Trapp@usdoj.gov COLUMBIA, South Carolina —-United States Attorney Bill Nettles announced a $24.9 million settlement with Amgen, Inc., a California based […]

Read more

FCA Whistleblowers Forced To Go It Alone As DOJ Drags Feet

By Dietrich Knauth This article was published in Law360 on April 12, 2013. With the rise in whistleblower cases under the False Claims Act, the U.S. Department of Justice is under pressure to unseal cases in which it hasn’t made a definitive decision whether or not to intervene, forcing whistleblowers to litigate more fraud cases […]

Read more

Whistleblower Bounties Will Prevent Future Fraud and Scandals

By Lianna Brinded This article was published on April 15, 2013 in the UK’s International Busines Times. Guttman says the UK has a lot to learn from the US on whistleblower incentives. The only way to prevent large scale scandals, such as Libor fixing and major financial fraud demonstrated by the collapse of Enron, is […]

Read more

Dr. Caroline Poplin’s Letter to the NY Times Editor in response to David Goldhill’s Op Ed entitled “The Health Benefits That Cut Your Pay”

To the Editor: With the best intentions, David Goldhill has described a free-market fantasy of health care. Market prices are based on power. In the United States today, hospitals and large doctor groups wield enormous market power, and they exercise it ruthlessly; consumers have none. Hospitals charge whatever the market will bear; uninsured patients pay […]

Read more

Court finds Circle C Construction, LLC, liable for falsifying certifications, but remands for further proceedings to determine damages

The United States Court of Appeals for the Sixth Circuit has affirmed a District Court ruling holding Circle C Construction, LLC, liable under the False Claims Act for submitting false payroll certifications, while remanding the case for further determinations about damages.  Circle C’s contract –for construction work at a Kentucky military installation –explicitly incorporated the […]

Read more

Comprehensive Conference on Litigation Class Actions

December 6 & 7, 2012 | Chicago, IL This conference is designed to provide a cutting-edge and in-depth exploration of this vibrant area of the law. Our faculty is comprised of leading class action practitioners, judges and service providers from across the United States who will discuss strategies from both plaintiffs’ and defendants’ perspectives. This […]

Read more

Top